Login
Navigate Fool.com
Will OPK beat
the market?

Opko Health, Inc.

NYSE: OPK

Community Rating: 2 Stars: Unattractive

8.14 -0.19 (-2.28%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.29
Previous Close $8.33
Daily Range $8.05 - $8.37
52-Week Range $6.14 - $12.95
Market Cap $3.4B
P/E Ratio -26.03
Dividend (Yield) $0.00 (0.0%)
Volume 3,319,138
Average Daily Volume 2,903,349
Current FY EPS -$0.38

How do you think OPK
will perform against the market?

Top OPK Bull/Bear Pitches

 

MoneyForHire (< 20)
Submitted July 9, 2008

Its going to be a few years until we see major gains in this stock, but when we do, expect them to be significant.

0 Replies Reply Report this Post
 

zzlangerhans (< 20)
Submitted August 15, 2008

The huge float makes Opko seem deceptively cheap. But 350M for a completely unproven siRNA therapy with a scam artist like Philip Frost at the wheel is definitely not cheap. Why anyone entrusts this g … More

2 Replies Reply Report this Post

News & Commentary Rss Feed

Morning Movers in Biotech: Medicines Co., Omeros Corporation, Opko Health, Inc. and VIVUS, Inc.

Today's top stories in health care and biotech.

Thursday 4/17 Insider Buying Report: SHLD, OPK

Insider Stock Trading: Phillip Frost Continues to Increase Stake in Opko Health; JPMorgan Sees Four

Plus, purchases at Ameresco and Ruby Tuesday.

Stocks: Insiders Buy at Opko Health and Conn's Inc.

Plus, purchases at Synta Pharmaceuticals and General Moly.

Stocks: Insiders Buy at Opko Health and Conn's

Plus, purchases at Synta Pharmaceuticals and General Moly.

Stocks: Bill Gross Buys Shares of Pimco Funds; Phillip Frost Buys Shares of Opko Health

Plus, a purchase at Oiltanking Partners.

Stocks: Insiders Buy at Opko Health and Retrophin

Plus, purchases at Bingo.com and PMC Commercial Trust.

Stocks: Insiders Buy at Staples, BJ's Restaurants, and Retrophin

Plus, a purchase at Mannatech.

Why 2014 May Be a Big Year for Opko Health, Inc.

Opko's (OPK) has a number of catalysts this year that could have a big impact on its biggest investor, Philip Frost; including a Tesaro's (TSRO) potential FDA filing for Rolapitant.

Opko Health Breaks Below 200-Day Moving Average - Notable for OPK

See More OPK News...

Sector

Healthcare

Industry

Healthcare Information Services

Opko Health, Inc. (OPK) Description

Opko Health Inc. is engaged in the development and commercialization of pharmaceutical products vaccines diagnostic technologies and imaging systems. Website: http://www.opko.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks